The median TTR was 5.6 months per protocol and 4.6 months when analyzed clinically 1 ; there was a nonsignificant trend toward shorter TTR when analyzed according to iwCLL clinical recommendations ( Figure 1 A).
← all excerpts
Frequent response monitoring in chronic lymphocytic leukemia clinical trials: what is the value?
1
—
—